申请人:CALASIA PHARMACEUTICALS, INC.
公开号:US20160311795A1
公开(公告)日:2016-10-27
The present application describes organic compounds that inhibit the activity of cytosolic heat shock protein Hsp90. Also described are methods useful for prophylaxis, treatment, or amelioration of symptoms of diseases or conditions that are responsive to inhibition of Hsp90 activity, such as neurological diseases, proliferative disorders, and infection.